Literature DB >> 28537430

Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance.

Elie Hatem1,2, Nadine El Banna1,2, Meng-Er Huang1,2.   

Abstract

SIGNIFICANCE: Glutathione is the most abundant antioxidant molecule in living organisms and has multiple functions. Intracellular glutathione homeostasis, through its synthesis, consumption, and degradation, is an intricately balanced process. Glutathione levels are often high in tumor cells before treatment, and there is a strong correlation between elevated levels of intracellular glutathione/sustained glutathione-mediated redox activity and resistance to pro-oxidant anticancer therapy. Recent Advances: Ample evidence demonstrates that glutathione and glutathione-based systems are particularly relevant in cancer initiation, progression, and the development of anticancer drug resistance. CRITICAL ISSUES: This review highlights the multifaceted roles of glutathione and glutathione-based systems in carcinogenesis, anticancer drug resistance, and clinical applications. FUTURE DIRECTIONS: The evidence summarized here underscores the important role played by glutathione and the glutathione-based systems in carcinogenesis and anticancer drug resistance. Future studies should address mechanistic questions regarding the distinct roles of glutathione in different stages of cancer development and cancer cell death. It will be important to study how metabolic alterations in cancer cells can influence glutathione homeostasis. Sensitive approaches to monitor glutathione dynamics in subcellular compartments will be an indispensible step. Therapeutic perspectives should focus on mechanism-based rational drug combinations that are directed against multiple redox targets using effective, specific, and clinically safe inhibitors. This new strategy is expected to produce a synergistic effect, prevent drug resistance, and diminish doses of single drugs. Antioxid. Redox Signal. 27, 1217-1234.

Entities:  

Keywords:  carcinogenesis; drug resistance; glutathione; glutathione-based systems; redox-based anticancer strategy

Mesh:

Substances:

Year:  2017        PMID: 28537430     DOI: 10.1089/ars.2017.7134

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  17 in total

1.  Enhanced antitumor effect of L-buthionine sulfoximine or ionizing radiation by copper complexes with 2,2´-biquinoline and sulfonamides on A549 2D and 3D lung cancer cell models.

Authors:  J F Cadavid Vargas; C Villa Perez; D B Soria; A Guerci; A L Di Virgilio
Journal:  J Biol Inorg Chem       Date:  2022-03-05       Impact factor: 3.358

2.  Association of Polymorphisms of Glutamate Cysteine Ligase Genes GCLC C-129 T and GCLM C-588 T with Risk of Polycystic Ovary Syndrome in Chinese Women.

Authors:  Chunyi Yang; Mingrong Xi; Hongwei Liu; Huai Bai; Chenyu Jiang; Qingqing Liu; Ping Fan
Journal:  Reprod Sci       Date:  2021-10-12       Impact factor: 3.060

3.  Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis.

Authors:  Sean C Tompkins; Ryan D Sheldon; Adam J Rauckhorst; Maria F Noterman; Shane R Solst; Jane L Buchanan; Kranti A Mapuskar; Alvin D Pewa; Lawrence R Gray; Lalita Oonthonpan; Arpit Sharma; Diego A Scerbo; Adam J Dupuy; Douglas R Spitz; Eric B Taylor
Journal:  Cell Rep       Date:  2019-09-03       Impact factor: 9.423

4.  β-Phenethyl Isothiocyanate Induces Cell Death in Human Osteosarcoma through Altering Iron Metabolism, Disturbing the Redox Balance, and Activating the MAPK Signaling Pathway.

Authors:  Huanhuan Lv; Chenxiao Zhen; Junyu Liu; Peng Shang
Journal:  Oxid Med Cell Longev       Date:  2020-04-04       Impact factor: 6.543

Review 5.  Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.

Authors:  Pierpaola Davalli; Gaetano Marverti; Angela Lauriola; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

6.  One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy.

Authors:  Xiaojuan Zhang; Chuanchuan He; Xiaoguang Liu; Yan Chen; Pengxuan Zhao; Chen Chen; Ruicong Yan; Minsi Li; Ting Fan; Bouhari Altine; Tan Yang; Yao Lu; Robert J Lee; Yongkang Gai; Guangya Xiang
Journal:  Theranostics       Date:  2020-02-03       Impact factor: 11.556

Review 7.  Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment.

Authors:  Jill Nehrbas; John T Butler; Ding-Wen Chen; Peter Kurre
Journal:  Front Oncol       Date:  2020-02-14       Impact factor: 6.244

8.  Particulate Matter (PM2.5) from Biomass Combustion Induces an Anti-Oxidative Response and Cancer Drug Resistance in Human Bronchial Epithelial BEAS-2B Cells.

Authors:  Regina Merk; Katharina Heßelbach; Anastasiya Osipova; Désirée Popadić; Wolfgang Schmidt-Heck; Gwang-Jin Kim; Stefan Günther; Alfonso García Piñeres; Irmgard Merfort; Matjaz Humar
Journal:  Int J Environ Res Public Health       Date:  2020-11-06       Impact factor: 3.390

9.  Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis.

Authors:  Hongxia Tang; Chaoqun Li; Yue Zhang; Hongyue Zheng; Ying Cheng; Jingjing Zhu; Xiaojie Chen; Zhihong Zhu; Ji-Gang Piao; Fanzhu Li
Journal:  Theranostics       Date:  2020-08-02       Impact factor: 11.556

Review 10.  Oncometabolites and the response to radiotherapy.

Authors:  Kexu Xiang; Verena Jendrossek; Johann Matschke
Journal:  Radiat Oncol       Date:  2020-08-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.